BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13791499)

  • 21. TREATMENT OF THREATENED ABORTION WITH PROGESTERONE.
    Nilsson L
    Acta Obstet Gynecol Scand; 1964; 42(S6):128-35. PubMed ID: 14151817
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of the newerprogestins in infertility and abortion therapy.
    BARFIELD WE
    New Physician; 1962 Sep; 11():302-5. PubMed ID: 13864972
    [No Abstract]   [Full Text] [Related]  

  • 23. [The us eof intravenous progesterone in threatened abortion].
    JASSIN A; JULIAA JJ; GUPITO M
    Dia Med; 1962 Sep; 34():1816-7. PubMed ID: 13957539
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progesterone therapy in threatened abortion].
    BORTH R; DE WATTEVILLE H
    Med Hyg (Geneve); 1952 Aug; 10(223):316. PubMed ID: 13001380
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of vitamin E and progesterone in threatened abortion].
    PLASTUNOV AB
    Vopr Okhr Materin Det; 1962 Dec; 7():56-60. PubMed ID: 13943963
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of treatment by progesterone in the course of threatened abortion].
    de WATTEVILLE H
    Ann Ostet Ginecol; 1960 May; 82():484-9. PubMed ID: 13843167
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of threatened abortion with progesterone].
    MADERNA C
    Ann Ostet Ginecol; 1951 Sep; 73(9):1286-1306. PubMed ID: 14915335
    [No Abstract]   [Full Text] [Related]  

  • 28. PROGESTERONE AND 6-METHYL-17-ACETOXYPROGESTERONE IN THREATENED ABORTION AND PREMATURE LABOUR.
    FUCHS F
    Minerva Ginecol; 1965 Jan; 17():SUPPL:67-70. PubMed ID: 14304426
    [No Abstract]   [Full Text] [Related]  

  • 29. [TREATMENT OF THREATENED ABORTION WITH GESTAGENS AND TRANQUILIZERS].
    TOTH F; TREIT S
    Orv Hetil; 1964 Nov; 105():2234-8. PubMed ID: 14232615
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prognostic value of progesterone test in threatened abortion].
    ANDREOLI C
    Folia Endocrinol Mens Incretologia Incretoterapia; 1953 Feb; 6(1):115-26. PubMed ID: 13060401
    [No Abstract]   [Full Text] [Related]  

  • 31. [Corpus luteum hormone in threatened abortion with special reference to therapy with hydroxy-progesterone-capronate (proluton depot). (Electromyography and Prof. Ashitaka's urine reactions)].
    UEDA Y; OMICHI J; MATSUURA S
    Z Geburtshilfe Gynakol; 1959; 153():172-81. PubMed ID: 13840171
    [No Abstract]   [Full Text] [Related]  

  • 32. ON THREATENED ABORTION.
    HANSEN H; NILSSON L; ZETTERGREN L
    Acta Obstet Gynecol Scand; 1963; 42():117-29. PubMed ID: 14057530
    [No Abstract]   [Full Text] [Related]  

  • 33. [Associated hormone therapy (estrogens-progesterone) of threatened abortion].
    CARBONINI M
    Ann Ostet Ginecol; 1951 Oct; 73(10):1319-41. PubMed ID: 14915337
    [No Abstract]   [Full Text] [Related]  

  • 34. [HORMONAL TREATMENT OF THREATENED ABORTION].
    BRUNO RO
    Sem Med; 1963 Nov; 123():1701-7. PubMed ID: 14111253
    [No Abstract]   [Full Text] [Related]  

  • 35. Observations on the use of progesterone in threatened abortion with special reference to pregnandiol excretion as a guide to therapy.
    GUTERMAN HS; TULSKY AS
    Am J Obstet Gynecol; 1949 Sep; 58(3):495-502. PubMed ID: 18137073
    [No Abstract]   [Full Text] [Related]  

  • 36. [Water-soluble progesterone in the protective therapy of the state of pregnancy].
    POMINI P
    Clin Ostet Ginecol; 1963 Apr; 65():191-6. PubMed ID: 13972090
    [No Abstract]   [Full Text] [Related]  

  • 37. [ON THE QUESTION OF PROGESTERONE TREATMENT IN PREMATURE LABOR].
    SCHWALM H; MOSLER KH
    Zentralbl Gynakol; 1965 May; 87():596-602. PubMed ID: 14341546
    [No Abstract]   [Full Text] [Related]  

  • 38. Experiments on the suppressive effect of a synthetic gestagen on the activity of the pregnant human uterus.
    BENGTSSON LP
    Acta Obstet Gynecol Scand; 1962; 41():124-43. PubMed ID: 13867214
    [No Abstract]   [Full Text] [Related]  

  • 39. [Allyloestrenol, active gestagen without virilizing action in therapeutic doses].
    LAMBILLON J
    Brux Med; 1961 Nov; 41():1601-8. PubMed ID: 14461762
    [No Abstract]   [Full Text] [Related]  

  • 40. THE EFFECT OF TREATMENT OF ABORTION-PRONE WOMEN WITH SECROSTERON AND PROVERA.
    Krieger VI
    Aust N Z J Obstet Gynaecol; 1963 Sep; 3(3):129-31. PubMed ID: 14065030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.